To investigate whether
amiodarone increases
interleukin-6 (IL-6) production in thyrocytes, human follicles obtained from subtotally thyroidectomized patients with
Graves' disease were cultured in serum-free medium supplemented with various concentrations of bovine
thyrotropin (bTSH) and
amiodarone. The follicles gradually formed monolayer cells and secreted
triiodothyronine (T3),
thyroglobulin (Tg), and
IL-6 for at least 14 days. TSH dose-dependently increased T3 and Tg but not
IL-6 levels in the
conditioned medium.
Amiodarone exerted no significant effect on T3, Tg, or
IL-6 concentrations at 0.1-1 microM. In contrast,
at 10-20 microM, it decreased T3 and Tg, but increased
IL-6 levels, and these changes were accompanied by increased expression of
IL-6 mRNA.
Amiodarone-induced
IL-6 production was inhibited by
prednisolone at 10(-7) M. Electron microscopic examination revealed that the thyroid follicles in the
suspension culture remained intact at 1 microM, but that cytotoxic effects (decreased microvilli and increased onion-like inclusion bodies) occurred at higher concentrations (10-25 microM). These in vitro findings indicate that
amiodarone does not impair thyroid function at clinically attainable serum levels (1 microM), but exerts cytotoxic effect by inducing the production of a proinflammatory
cytokine (IL-6) at higher concentrations. Because
amiodarone-induced
IL-6 production was inhibited by
prednisolone, it is reasonable to administer
glucocorticoids to patients with
amiodarone-induced destructive
thyrotoxicosis (type II).